AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...

Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story FDA reverses course on Juul The Food and Drug Administration is allowing Juul Labs to keep its electronic ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10 to 12 months for a review to ...

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...